Predictive significance of T cell subset changes during
T lymphocyte phenotype
advanced non-small cell lung cancer
dendritic cell-cytokine-induced killer cell immunotherapy
ex vivo culture
regulatory T cells
Journal
Oncology letters
ISSN: 1792-1074
Titre abrégé: Oncol Lett
Pays: Greece
ID NLM: 101531236
Informations de publication
Date de publication:
Dec 2019
Dec 2019
Historique:
received:
30
05
2019
accepted:
06
06
2019
entrez:
3
12
2019
pubmed:
4
12
2019
medline:
4
12
2019
Statut:
ppublish
Résumé
Adoptive T cell immunotherapy with cytokine-induced killer cells (CIKs) has been demonstrated to prolong the survival of patients with advanced non-small cell lung cancer (NSCLC). The aim of the present study was to evaluate whether the expansion of effector T cells and the decrease of regulatory T cells (Tregs) that occurred during the
Identifiants
pubmed: 31788044
doi: 10.3892/ol.2019.10964
pii: OL-0-0-10964
pmc: PMC6865835
doi:
Types de publication
Journal Article
Langues
eng
Pagination
5717-5724Informations de copyright
Copyright: © Huang et al.
Références
Immunol Rev. 2014 May;259(1):245-58
pubmed: 24712470
Onco Targets Ther. 2017 Sep 22;10:4687-4690
pubmed: 29026316
Cancer Biother Radiopharm. 2017 Aug;32(6):221-226
pubmed: 28820635
Immunotherapy. 2017 Nov;9(14):1165-1174
pubmed: 29067881
Clin Cancer Res. 2017 Sep 1;23(17):5066-5073
pubmed: 28611200
J Immunol. 2007 Oct 1;179(7):4323-34
pubmed: 17878327
Cancer Immunol Immunother. 2014 Sep;63(9):939-46
pubmed: 24916038
Am J Clin Oncol. 1982 Dec;5(6):649-55
pubmed: 7165009
Immunology. 2015 Oct;146(2):185-93
pubmed: 26190355
Oncotarget. 2015 Aug 21;6(24):20278-87
pubmed: 26109430
Anticancer Res. 2017 Jul;37(7):3947-3954
pubmed: 28668899
Clin Transl Oncol. 2013 Oct;15(10):780-8
pubmed: 23359185
Oncotarget. 2017 Jan 24;8(4):7003-7013
pubmed: 27690294
Nat Rev Cancer. 2008 Apr;8(4):299-308
pubmed: 18354418
Oncoimmunology. 2016 Dec 7;6(4):e1264563
pubmed: 28507788
Cancer Lett. 2014 Feb 1;343(1):42-50
pubmed: 24045039
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90
pubmed: 21296855
Crit Rev Diagn Imaging. 1989;29(3):307-35
pubmed: 2667567
J Clin Invest. 2013 Jun;123(6):2447-63
pubmed: 23728179
J Immunol Res. 2015;2015:251657
pubmed: 26236751
Clin Transl Oncol. 2019 Jun;21(6):721-728
pubmed: 30374838
Cancer Immunol Immunother. 2005 Dec;54(12):1162-71
pubmed: 15889254
Oncotarget. 2015 Dec 1;6(38):41350-9
pubmed: 26462021
J Exp Med. 2007 Mar 19;204(3):547-57
pubmed: 17312008
Immunol Lett. 2017 Mar;183:37-43
pubmed: 28143792
Lancet. 2017 Jan 21;389(10066):299-311
pubmed: 27574741
Immunity. 2015 Sep 15;43(3):579-90
pubmed: 26341400
J Exp Med. 2013 Oct 21;210(11):2435-66
pubmed: 24127486
J Cancer Res Clin Oncol. 2011 Feb;137(2):305-10
pubmed: 20407789
Immunotherapy. 2017 Mar;9(5):411-421
pubmed: 28357913
Clin Cancer Res. 2019 Mar 1;25(5):1494-1504
pubmed: 30514775
Oncotarget. 2017 May 9;8(19):31318-31328
pubmed: 28412743